KSF News, Updates, & Insights

Final Approval of $7.75 Million Settlement Granted in GW Pharma Securities Litigation

Kurt Ziegler, et al. v. GW Pharm., PLC, et al., No. 3:21-cv-01019-BAS-MSB (S.D. Cal). On April 4, 2024, after nearly three years of litigation, the Hon. Cynthia Bashant entered a Final Judgment approving a $7.75 million settlement for the Class in a Class action for breach of federal securities laws relating to a proposed merger of pharmaceutical company GW Pharmaceuticals.